For most investors, the stock market is a popularity contest. For me, it's a scavenger hunt. I'm not looking for the stocks everyone already loves. By the time financial television is discussing them nonstop and social media has turned them into cults, the easy money is often gone. The crowd has arrived. The narrative has formed. The expectations are sky-high. I'm looking for something different. I'm looking for catalysts. Specifically, I'm looking for moments when reality is changing faster than Wall Street's perception of reality. That's where pharmaceutical stocks become fascinating. Not because they're easy. Not because they're predictable. And certainly not because they don't occasionally resemble a casino run by molecular biologists. They're fascinating because few sectors create larger disconnects between present value and future value. A biotech company can look worthless today and become enormously valuable tomorrow. Like...
Why Money Never Sits Still, Why Investors Chase Yesterday’s Winners, and Why the Biggest Opportunities Often Appear When Nobody Wants Them If there's one lesson the market keeps teaching me, it's this: Money is restless. It never sits still. It never falls in love. It never stays loyal. It never cares about the story investors tell themselves. Capital is constantly searching for its next destination, moving from fear to optimism, from caution to speculation, from safety to innovation, and then right back again. Watching this happen is like watching human psychology perform interpretive dance while wearing a suit. Everyone thinks they're making rational decisions. Meanwhile, trillions of dollars are stampeding from one corner of the market to another because somebody used the phrase "AI opportunity" on an earnings call. The longer I invest, the more I realize that understanding capital rotation is often more important than understanding individual compan...